Manuela Valente Biography and Net Worth

Insider of SOPHiA GENETICS

Manuela Da Silva Valente, B.A., is a seasoned human resources executive with more than 20 years of experience working in international companies. Manuela joined SOPHiA GENETICS in January 2019 as our Chief People Officer from IQVIA (formerly Quintiles and IMS Health, Inc.), a human data science company, where she had a number of senior human resources roles, including from 2016 to 2018 the position of Global Senior Director of Human Resources.

Prior to this, she worked for several years at Outcome Sciences, where she successfully established European operations and led the organization through an acquisition by Quintiles.

Manuela obtained a Bachelor’s degree in business administration from the Business Management School of Zurich and a management & human resources diploma from CEFCO Lausanne.

Used to working in fast-pacing companies, Manuela has extensive experience in aligning people strategies with business objectives and driving significant organizational and cultural changes by focusing on talent development and employee engagement.

What is Manuela Valente's net worth?: The estimated net worth of Manuela Valente is at least $1.13 million as of April 20th, 2026. Ms. Valente owns 215,071 shares of SOPHiA GENETICS stock worth more than $1,134,500 as of May 1st. This net worth approximation does not reflect any other assets that Ms. Valente may own. Learn More about Manuela Valente's net worth.
How do I contact Manuela Valente?: The corporate mailing address for Ms. Valente and other SOPHiA GENETICS executives is , , . SOPHiA GENETICS can also be reached via phone at 41-21-694-1060. Learn More on Manuela Valente's contact information.
Has Manuela Valente been buying or selling shares of SOPHiA GENETICS?: Over the course of the past ninety days, Manuela Valente has sold $44,688.97 of SOPHiA GENETICS stock. Most recently, Manuela Valente sold 380 shares of the business's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $5.20, for a transaction totalling $1,976.00. Following the completion of the sale, the insider now directly owns 215,071 shares of the company's stock, valued at $1,118,369.20. Learn More on Manuela Valente's trading history.
Who are SOPHiA GENETICS's active insiders?: SOPHiA GENETICS's insider roster includes Jurgi Camblong (Founder and CEO), George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Kevin Puylaert (SVP, Chief Sales Officer), Manuela Valente (Insider), and Abhimanyu Verma (EVP, Chief Technology Officer). Learn More on SOPHiA GENETICS's active insiders.
Are insiders buying or selling shares of SOPHiA GENETICS?: In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company. Learn More about insider trades at SOPHiA GENETICS.
Information on this page was last updated on 4/27/2026.

Manuela Valente Insider Trading History at SOPHiA GENETICS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/20/2026	Sell	380	$5.20	$1,976.00	215,071
4/8/2026	Sell	3,824	$4.85	$18,546.40	215,451
4/7/2026	Sell	2,376	$4.87	$11,571.12	219,275
4/6/2026	Sell	2,597	$4.85	$12,595.45	221,651
3/19/2026	Sell	380	$4.79	$1,820.20	152,379

Manuela Valente Buying and Selling Activity at SOPHiA GENETICS

SOPHiA GENETICS Company Overview

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Today's Range

Now: $5.32

$5.23

$5.37

50 Day Range

MA: $4.81

$4.10

$5.28

2 Week Range

Now: $5.32

$2.59

$5.70

Volume

51,479 shs

Average Volume

169,220 shs

Market Capitalization

$364.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04